2019 Cannabis Business Award's Publication of the Year |
FMCPG HAS BEEN SERVING
AND REPRESENTING THE CANNABIS PHYSICIAN COMMUNITY SINCE 2020 |
THE "FLORIDA MEDICAL CANNABIS PHYSICIAN GROUP" (FMCPG) FOR ALL
"MEDICAL MARIJUANA DOCTORS" AND "MMTC DIRECTORS ONLY " DISCUSSION WILL INCLUDE: SUMMARY OF BILLS AND FINAL OUTCOMES FOR 2025 IN TALLAHASSEE THAT WILL AFFECT THE WAY YOU CONDUCT YOUR MEDICAL PRACTICE TRUMP APPOINTMENTS EFFECT ON THE CANNABIS INDUSTRY IN FLORIDA
REVIEW OF THE OMMU AND CHANGES TO THE DOCTOR'S PATIENT INPUT PORTAL ON THE OMMU WEBSITE.
DOCTORS WITHIN OUR GROUP WILL DISCUSS HOW THEY HAVE BEEN WORKING AROUND SOME OF THE CHANGES
REF'S ISSUES AND SOLUTIONS
USE THIS LINK TO JOIN MEETING TO PRE- REGISTRATION - THURSDAY, MAY 22, 2025
CLICK HERE ON LINK BELOW
https://us02web.zoom.us/meeting/register/ivgS2xs5TKu4yZt0oYT8Hw |
MEDICAL CANNABIS PHYSICIAN PROMOTION PACKAGE BY CANNABIS NEWS FLORIDA
ARTICLE: Physician will contribute an article of 350 words**. This article will appear in the Cannabis News Florida e-newsletter for one month (4 weeks).
E-MAIL BLAST: Cannabis News Florida will send out one e-mail blast promoting the Physician to the other physicians in three zip code areas or one city to be determined by the Physician. The Physician will supply the information for the email blast. The Article above can be used in the e-mail blast.
The cost of this program is ONLY $500.
**Cannabis News Florida will assign a writer for a telephone interview with the Physician and create the article to be published. Physician shall have the right to review and approve the article before publication for an additional cost of $100.
IF YOU ARE INTERESTED, PLEASE EMAIL ME AT CHARLES@CANNABISNEWSFLORIDA.COM OR CALL MY CELL AT 954-605-4785 |
NEWS FROM THE PAST WEEK
RELATING TO THE BUSINESS OF MMTC'S
IN FLORIDA Click on Company Logo to be Transferred to Web Site
|
Trulieve-Branded Dispensary to Open in Lorain, Ohio
New Lorain County dispensary will host grand opening celebration Friday, May 16th
TALLAHASSEE, Fla., May 14, 2025 — Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the U.S., today announced the opening of a new Trulieve-branded dispensary in Lorain, Ohio. Harvest Grows LLC will operate the dispensary under the Trulieve brand through a licensing agreement with the Company.
The dispensary will host a grand opening celebration Friday, May 16, featuring specials and promotional giveaways.
“We are thrilled to open this new dispensary under our licensing agreement with Trulieve,” said Harvest’s Chief Executive Officer, Mark Eiland. “We are proud to be associated with the Trulieve brand and look forward to serving customers at this new location.”
READ MORE |
Trulieve Rewards Trulieve Rewards is a customer rewards program offering patients and customers in participating states an easy platform to earn points on every purchase at Trulieve dispensaries. We've revamped and refreshed our old cannabis loyalty program to reward cannabis enthusiasts loyal to Trulieve with savings, perks, and points every time they shop for cannabis products JOIN NOW | Curaleaf International Launches a Range of Medical Cannabis Products in Australia
May 15, 2025 — Curaleaf International, part of Curaleaf Holdings, Inc. (TSX:CURA) a leading international provider of medical cannabis products, today announced the launch of Curaleaf branded products in Australia. This announcement marks the expansion of Curaleaf’s presence in one of the world’s fastest growing medical cannabis markets and underscores its commitment to local collaboration, clinical integrity, and patient care.
The initial product offering, comprising four cannabis flower strains, will be distributed via Canngea, a licensed Australian manufacturer and wholesaler with a wealth of experience in medical cannabis. This partnership supports Curaleaf’s vision to be the world’s leading cannabis company by consistently delivering superior products and services.
Over the coming months, patients and healthcare professionals in Australia can look forward to a broader portfolio and further innovative solutions offered by Curaleaf, including precision-dosed inhalation formats and popular strains already widely prescribed across the UK, Germany, and other key European markets.
READ MORE |
Curaleaf Celebrates New Dispensary Opening in Lima, Ohio
The Company’s newest Ohio location features drive-through pick-up and expanded access for customers
May 16, 2025 – Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer cannabis products, today announced the opening of its newest dispensary in Lima, Ohio, located at 2151 Elida Rd. The store expands Curaleaf’s footprint in the Buckeye State to three stores, bringing the Company’s nationwide retail footprint to 152 locations. Curaleaf Lima will increase convenient access to high-quality cannabis for both medical patients and adult-use customers across northwest Ohio.
Curaleaf Lima is open Sunday from 9:00 AM to 7:00 PM and Monday through Saturday from 9:00 AM to 8:00 PM ET. The dispensary is located next to vibrant local businesses and features a drive-through pick-up window, offering added speed and accessibility for order fulfillment. Customers can explore a wide variety of trusted, best-in-class brands and products including Select BRIQ all-in-one vapes, Grassroots high-quality flower, JAMS edibles, and Find flower.
READ MORE |
Red White & Bloom Brands Provides Update on Status of Management Cease Trade Order
TORONTO, May 15, 2025– Red White & Bloom Brands Inc. (CSE: RWB) (“RWB” or the “Company”) is providing this update on the status of a management cease trade order granted on May 1, 2025 (the “MCTO”) by the British Columbia Securities Commission under National Policy 12-203 – Management Cease Trade Order (“NP 12-203”).
On May 1, 2025, the Company announced that, for reasons disclosed in the news release, there would be a delay in the filing of its financial statements and accompanying management’s discussion and analysis for the fiscal year ended December 31, 2024 (the “Annual Filings”) beyond the period prescribed under applicable Canadian securities laws (the “Default Announcement”).
The Company reports that the audit continues to progress and the Company will provide a further update on the timing of its Annual Filings on or about May 30, 2025 if it has not filed prior to this date. The Company is also progressing on completion of its interim financial statements and accompanying management’s discussion and analysis for the first quarter ended March 31, 2025, and will provide a further update on or before May 30, 2025. Further updates on timing will be provided by the Company as necessary.
READ MORE |
FLUENT Launches KNACK Whole Flower Brand in Florida, Expanding New York Line to the Sunshine State
May 20, 2025 — FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), a national cannabis company operating under the FLUENT™ brand, proudly announces the Florida launch of KNACK, its whole flower brand already trusted by New York consumers. Featuring a curated, rotating selection of hybrid, indica, and sativa strains in a 3.5-gram format, KNACK is now available at all 35 FLUENT dispensaries across Florida.
KNACK originally debuted in New York, where it quickly gained traction for delivering high-quality, flavorful, and affordable flower to everyday consumers. The brand is also available at third-party dispensaries in New York via ENTOURAGE wholesale platform.
The introduction of KNACK in Florida represents a milestone in FLUENT’s ongoing evolution and renewed focus on raising the standard of whole flower throughout the state. With revamped cultivation practices, refined genetics, and a deeper connection to consumer preferences, FLUENT is doubling down on quality and consistency.
Robert Beasley, CEO of FLUENT, shared his thoughts on the launch:
“KNACK’s expansion into Florida is more than just a product launch—it’s a reflection of the progress we’ve made in refining our flower quality. We’ve listened to our community, invested in our cultivation facilities, and made major improvements to bring Florida consumers the kind of flower they expect from a top-tier brand.”
READ MORE |
Planet 13 Announces Chief Financial Officer Resignation;
Steve McLean Named Interim Chief Financial Officer
May 20, 2025 — Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, today announced that Dennis Logan, the Chief Financial Officer of the Company, submitted his resignation effective May 31, 2025. Mr. Logan will be leaving the Company to pursue other opportunities.
Mr. Logan has served as the Chief Financial Officer of the Company since 2018 and is committed to an orderly transition of his duties. Effective upon Mr. Logan’s departure, the Company has appointed Steve McLean, the Company’s Vice President of Finance to serve as its Interim Chief Financial Officer.
“We would like to thank Dennis for his contributions to the Company. He has been a key contributor to Planet 13 since we went public. We wish him the best in his future endeavors,” said Robert Groesbeck, Co-Chief Executive Officer of the Company.
READ MORE
|
Planet 13 Announces Q1 2025 Financial Results
Q1 2025 Revenue of $28.0 million
Q1 2025 Net loss of $2.0 million
Q1 2025 Adjusted EBITDA loss of $2.5 million
All figures are reported in United States dollars ($) unless otherwise indicated
LAS VEGAS, May 14, 2025 — Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, today announced its financial results for the three-month period ended March 31, 2025. Planet 13’s financial statements are prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”).
“This was a challenging quarter, marked by persistent pricing pressure and softness in tourism and consumer spending. Despite the headwinds, our differentiated brands and focus on entertainment continue to drive relative outperformance, reinforcing the strength and resilience of our portfolio,” said Larry Scheffler, co-CEO of Planet 13.
“We are moving with urgency to align our cost base to the realities of today’s market. These actions are focused on sharpening our operational efficiency, enhancing profitability, and prioritizing investments in our most strategic and high-performing assets. By concentrating on what we do best, we’re positioning the company for stronger, more sustainable growth,” said Bob Groesbeck, co-CEO of Planet 13.
Financial Highlights – Q1 – 2025
Operating Results
All comparisons below are to the quarter ended March 31, 2024, unless otherwise noted
Revenue was $28.0 million as compared to $22.9 million, an increase of 22.5%. The increase in sales was driven by the addition of Florida.
Gross profit was $12.0 million or 42.8% as compared to $10.5 million or 45.8%. The lower gross margin was driven by industry wide pricing pressure.
Total expenses were $18.6 million as compared to $14.1 million, a increase of 31.6%.
Higher total expenses were driven by the addition of Florida operations.
Net loss of $2.0 million as compared to a net loss of $5.9 million.
Adjusted EBITDA loss of $2.5 million as compared to Adjusted EBITDA loss of $0.0 million. Adjusted EBITDA loss was driven by lower operating leverage.
READ MORE
|
Cannabis Company M&A Transactions by Industry Sector |
The Cultivation & Retail sector leads all sectors in total M&A transaction value with $567.3M in total deal consideration for the LTM period ended 5/16/25, representing an 11.2% decline vs the same period in 2024.
The Infused Products & Extracts sector ranks second in total M&A consideration at $421.1M for this period, representing a 990.0% increase vs the same period in 2024.
The Real Estate sector ranks third in total M&A consideration at $58.9M for the same period.
View This Week's Viridian Sector Deal Tracker For a Deeper Dive Into M&A and Capital Raise Transactions by Industry Sector
Wondering What Your Cannabis Business Is Worth? Contact Us We'll Give You the Facts From Our Proprietary Deal Data About Viridian Capital Advisors
Since launching in 2014, Viridian Capital Advisors has become one of the most respected and experienced advisory and M&A firms specializing in the cannabis industry. We provide a wide range of services, including:
Strategic Advisory Consulting: Including valuation, financial modeling, restructuring and fairness opinions. Mergers & Acquisitions: Transaction advisory and execution. Capital Raises: Including debt and equity.
Many of our assignments begin with a basic question: "What should I do now?"
Raise capital to expand? What kind of capital is most appropriate?
Acquire another company? What are the advantages and pitfalls?
Sell my company? What valuations can i achieve? What transaction structures are possible? Put our experience, data and depth of senior talent behind your next transaction.
Contact
Scott Greiper
CEO
Viridian Capital Advisors, LLC
646.330.0704
sgreiper@viridianca.com
Frank Colombo
Managing Director
Viridian Capital Advisors, LLC
914.523.4730
fcolombo@viridianca.com |
NATIONAL AND INTERNATIONAL NEWS |
Blum Holdings Inc. Reports First Quarter 2025 Financial Results
Revenue Growth of 26% Year-over-Year, EBITDA Turns Positive Amid Operating Improvements and Streamlined Cost Structure, Net Loss Reduced by Over 80%
DOWNEY, Calif., May 14, 2025 — Blum Holdings, Inc. (OTCQB: BLMH) (the “Company,” “Blüm,” “Blüm Holdings,” “we” or “us”), a California-based publicly traded holding company and cannabis operator, announced its financial results for the first quarter ended March 31, 2025.
Key Highlights from First Quarter 2025
Revenue increased 26% to $2.2 million, compared to $1.8 million in Q1 2024. The increase was primarily driven by the successful divestiture of underperforming Bay Area assets in the prior quarter and the addition of Northern California retail stores in Q2 2024, reflecting the integration of new operating units and improved regional footprint.
Gross margin improved to 53%, up from 45% in Q1 and Q4 2024, driven by stronger pricing discipline and product mix optimization.
Operating expenses declined to $2.5 million, down from $4.4 million in Q1 2024, reflecting meaningful cost containment, targeted selling, general, and administrative (“SG&A”) expense reductions, and completion of strategic legacy restructuring.
Net loss from continuing operations was $0.6 million, a substantial improvement from $3.5 million in Q1 2024, demonstrating continued momentum in reducing losses.
Positive EBITDA was $57,000, compared to an EBITDA loss of $3.0 million in Q1 2024. This marks a milestone in Blüm’s operational turnaround and reflects improved operational efficiency across the business.
Adjusted EBITDA loss narrowed to $0.4 million, from $2.1 million in Q4 2024 and $3.3 million in Q1 2024—an improvement of 87% year-over-year and 80% quarter-over-quarter—underscoring steady progress toward sustainable profitability.
READ MORE |
Tilray Brands Announces the Launch of XMG Atomic Sours: New THC Beverages and Edibles
Nostalgic Sour Flavours Meet Cutting-Edge Cannabis Innovation
TORONTO, May 14, 2025 — Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, is excited to announce that its wholly-owned subsidiary, High Park Holdings Ltd., is launching XMG Atomic Sours, a new line of cannabis beverages and gummies that redefine the sour experience. XMG Atomic Sours includes two cannabis-infused drinks, Cherry Blasted Lime and Foggy Peaches, and two cannabis-infused gummies, Very Berry Rocket and Cherry Blasted Lime, all crafted to provide consumers with nostalgic sour flavours.
XMG Atomic Sours beverages, including Cherry Blasted Lime and Foggy Peaches, offer nostalgic super sour flavors. Each beverage contains 10mg THC, 10mg CBG, and Guarana extract, providing 30mg of naturally occurring caffeine. These beverages are fast-acting due to nano-emulsified THCA diamonds.
The XMG Atomic Sours Gummies, available in Very Berry Rocket and Cherry Blasted Lime flavors, mark the brand’s entry into the edibles market. This expansion diversifies the brands’ product portfolio and caters to emerging consumer preferences. Each gummy is shaped like a nostalgic “key” and comprises 10mg of nano-emulsified THC and 10mg of CBG. These gummies deliver an intensely sour experience and are crafted using plant-based pectin.
READ MORE |
Blum Holdings, Inc. Doubles Revenue Potential with Execution of Amended and Restated LOI, Accelerating Acquisition of Premier Northern California Dispensary
May 15, 2025 — Blum Holdings, Inc. (OTCQB: BLMH) (the “Company,” “Blüm,” “Blüm Holdings,” “we” or “us”), a California-based publicly traded holding company and cannabis operator, today announced the execution of an Amended and Restated Binding Letter of Intent (“A&R LOI”), as previously disclosed in press releases dated January 21, 2025 and February 4, 2025, to acquire 100% of the issued and outstanding common stock of a licensed retail cannabis operator located in Northern California (the “Target”).
Upon closing, this transaction is expected to generate over $12.0 million in revenue more than doubling Blüm’s annual revenue, significantly strengthening the Company’s retail presence and market position in California.
Under the revised terms, total consideration remains $2.0 million, structured as follows:
$1.3 million in cash, including the assignment of a previously funded $500,000 senior convertible promissory note, which will be structured as a Seller Note at closing, secured by the Target, with a thirty-month maturity fully amortized at 8% simple interest.
$500,000 in common stock of the Company at a revised per-share valuation of $1.15, reflecting a nearly 40% improvement from the original terms.
Additionally, the revised terms include the release of an escrowed payment of $800,000 immediately upon execution of the related Management Services Agreement (“MSA”), granting Blüm immediate operational and economic control of the Target. The parties anticipate executing the MSA promptly. Blüm expects to quickly finalize the definitive Stock Purchase Agreement (“SPA”) and related transaction documentation. The final closing remains subject to customary state and municipal regulatory approvals.
READ MORE |
BELOW ARE THE LINKS TO THE DIRECTORY OF FLORIDA CANNABIS DOCTORS AND
DISPENSARIES IN THE STATE OF FLORIDA |
QUALIFIED PATIENTS
OVER 915,000
AND 719 DISPENSING LOCATIONS |
LATEST OMMU REPORTS FROM OFFICE OF MEDICAL MARIJUANA USE IN THE STATE OF FLORIDA Highlights from
MAY 16, 2025 Report BY THE NUMBERS
Qualified Patients: (Active ID Card) MAY 16 2025- 915,073 MAY 09 2025- 914,180
MAY 02 2025- 913,159
APR 25 2025- 911,857
APR 18 2025- 911,401
APR 11 2025- 909,711
Patients Last Week: 893
Qualified Ordering Physicians: 2,136
New Doctors Last Week: - 255 Reporting Period: MAY 9 - MAY 15 2025
Amount of Medical Marijuana Dispensed - (mgs THC) 379,703.448
Amount of Low-THC Cannabis Dispensed - (mgs CBD) 31,698
Amount of Marijuana in a From for Smoking (oz) 132,684.321
Approved Dispensing Locations: 719
Added Last Week: 0 |
UPCOMING MEETING AND CONFERENCES |
ADVERTISEMENT OPPORTUNITIES
If your goal is to get your business in front of the right people in the cannabis industry or you want to be an integral part of this new and exciting business opportunity, then you need to join with Cannabis News Florida as we help to establish cannabis as a major part of the economy in Florida. Cannabis News Florida is an online publication focusing on both local and national news from leading authorities about the medical and business developments in the medical cannabis industry covering the entire state of Florida.
Join the Cannabis News Florida force online and in print. We offer several marketing options to fit all budgets:
· MMTC PROMOS LISTED IN EACH E-NEWSLETTER
• Directory Listing
• Banner Ads
• Ad Space in the Newspaper
• Feature Articles
• Weekly Newsletters
For further information or to make your ad reservation, please call:561-368-6950 / 954-605-4785 cell charles@cannabisnewsflorida.com
|
|
|